CVS will stop filling Cerebral and Done Health ADHD med prescriptions

CVS pharmacies will no longer fill prescriptions for controlled substances like Adderall from telehealth companies Cerebral and Done Health, The Wall Street Journal reported† It is the final blow to Cerebral, which faces investigations from the United States Department of Justice and the Drug Enforcement Administration.

Cerebral said last week it would stop prescribing controlled substances to new customers and take existing customers off the service by the fall. The company told The Wall Street Journal that it “did everything possible to ensure that these patients have access to medications that their health care providers have determined they need.”

Done Health is an ADHD-specific telehealth platform and, like Cerebral, was criticized by nurses who said they put under pressure to dispense medicines based on only short visits to customers. Some individual CVS sites had already stopped submitted prescriptions from some Done medics and had them questioned about the amount of ADHD medication they were prescribing. Walmart had also blocked prescriptions from some Done medics. Truepill, the preferred pharmacy reported by Cerebral, said this month it would no longer fill Adderall and the company’s other regulated drug prescriptions.

Normally, federal rules require patients to meet with a doctor in person before they can receive a controlled substance like Adderall. But those rules were relax when the United States had a public health emergency at the start of the COVID-19 pandemic in 2020, and doctors could prescribe the drugs with just a video visit. Companies like Cerebral and Done took advantage of that gap to offer prescriptions to customers.

The public health emergency is still in effect, so doctors can technically still prescribe controlled substances through telehealth. But most major telemedicine companies, such as Teladoc and MDLive, told The Wall Street Journal that they do not prescribe the drugs. And with pharmacies blocking prescriptions from those that do, there are fewer avenues for easier access to those drugs.

SOURCE – www.theverge.com

Leave a Reply

Your email address will not be published.